0.0(top 100%)
impact factor
692(top 20%)
papers
353(top 50%)
citations
7(top 50%)
h-index
0.1(top 100%)
extended IF
860
all documents
360
doc citations
14(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Overview: PAF Receptor Antagonists: Recent AdvancesCurrent Opinion in Therapeutic Patents199224
2Patent Update: ACAT InhibitorsCurrent Opinion in Therapeutic Patents199320
3Patent Update: Inhibitors of the Phospholipases A2Current Opinion in Therapeutic Patents199315
4Overview: Structure-Activity Relationships of Prostaglandin Analogues as Ocular Hypotensive AgentsCurrent Opinion in Therapeutic Patents199313
5Overview: Macrolide ImmunosuppressantsCurrent Opinion in Therapeutic Patents199310
6Patent Update: Phospholipase A2InhibitorsCurrent Opinion in Therapeutic Patents19927
7Overview: Recent Developments in AnxiolyticsCurrent Opinion in Therapeutic Patents19937
8Overview: Recent Advances in Angiotensin II Receptor AntagonistsCurrent Opinion in Therapeutic Patents19937
9Overview: Agonists, Antagonists and Modulators of the N-methyl-D-aspartic acid (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) Subtypes of Glutamate ReceptorsCurrent Opinion in Therapeutic Patents19936
10Anti-infectives Overview: The development of potential anti-influenza drugsCurrent Opinion in Therapeutic Patents19936
11Overview: Diabetes: New Chemical EntitiesCurrent Opinion in Therapeutic Patents19925
12Patent Update: Small Molecule ImmunomodulatorsCurrent Opinion in Therapeutic Patents19925
13Overview: Excitatory Amino Acid AntagonistsCurrent Opinion in Therapeutic Patents19925
14Overview: Dual-Action β-Lactam AntibacterialsCurrent Opinion in Therapeutic Patents19925
15Overview: Recent Advances in Organic NitratesCurrent Opinion in Therapeutic Patents19935
16Overview: Retroviral Vectors for Gene Therapy and TransgenicsCurrent Opinion in Therapeutic Patents19935
17Patent Update: Renin Angiotensin System: Recent Advances in Inhibitor DesignCurrent Opinion in Therapeutic Patents19935
18Overview: Therapeutic Uses of Cell-Matrix Adhesive ProteinsCurrent Opinion in Therapeutic Patents19935
19Patent Evaluation: Novel inhibitors of atherosclerotic intimal thickeningCurrent Opinion in Therapeutic Patents19935
20Overview: Challenges in the Search for CNS Therapeutics in the 1990'sCurrent Opinion in Therapeutic Patents19914
21Overview: Recent Advances in Elastase InhibitorsCurrent Opinion in Therapeutic Patents19924
22Overview: Oncologic, Endocrine & Metabolic Antisense oligonucleotides for the treatment of cancerCurrent Opinion in Therapeutic Patents19934
23Overview: Potent GABABAgonists and AntagonistsCurrent Opinion in Therapeutic Patents19934
24Overview: Recent Developments in Sulphidopeptide Leukotriene Receptor AntagonistsCurrent Opinion in Therapeutic Patents19923
25Overview: Excitatory Amino Acids;Current Opinion in Therapeutic Patents June 1992Current Opinion in Therapeutic Patents19923
26Patent Update: Neurokinin Receptor AntagonistsCurrent Opinion in Therapeutic Patents19933
27Patent News: Platelet-Activating Factor Receptor AntagonistsCurrent Opinion in Therapeutic Patents19933
28Overview: Virally Based Transient Expression SystemsCurrent Opinion in Therapeutic Patents19933
29Patent Update: Antibacterial Patent Activity: October 1992 to March 1993Current Opinion in Therapeutic Patents19933
30Patent Update: Lipoxygenase Inhibitors and Leukotriene Antagonists as Therapeutic AgentsCurrent Opinion in Therapeutic Patents19912
31Patent Update: Cholinergic Agents: Recent Advances December 1991 through June 1992Current Opinion in Therapeutic Patents19922
32Overview: New Antipsychotic Agents: A Patent Overview — 1991Current Opinion in Therapeutic Patents19922
33Patent Update: Potential Therapeutic Agents for the Treatment of Allergic and Gastrointestinal DisordersCurrent Opinion in Therapeutic Patents19922
34Patent Update: Agents for the Treatment of Neurodegenerative Diseases: Recent Advances, January Through June, 1992Current Opinion in Therapeutic Patents19922
35Patent Update: Antifungal Agents - Recent Patent ActivityCurrent Opinion in Therapeutic Patents19922
36Overview: Recent Developments in Antifilarial AgentsCurrent Opinion in Therapeutic Patents19922
37Overview: Inhibitors of Bone Resorption and Implications for TherapyCurrent Opinion in Therapeutic Patents19922
38Patent Evaluation: Growth Inhibition by OligonucleotidesCurrent Opinion in Therapeutic Patents19922
39Patent Update: Serotonergic Agents: June-December 1991Current Opinion in Therapeutic Patents19922
40Overview: Strategies for the Prevention of Graft RejectionCurrent Opinion in Therapeutic Patents19922
41Patent Update: Cerebral Anti-lschaemic Agents: Recent Advances, June Through December, 1991Current Opinion in Therapeutic Patents19922
42Patent Update: Inhibitors of Tyrosine Kinase Activity as Anticancer Therapeutics: Recent DevelopmentsCurrent Opinion in Therapeutic Patents19932
43Overview: Biotinylated Monoclonal Antibodies: Their Potential for Diagnosis and Therapy of CancerCurrent Opinion in Therapeutic Patents19932
44Patent Update: Anti-inflammatory Patent Highlights from the Second Half of 1992Current Opinion in Therapeutic Patents19932
45April CNS Patent DistributionCurrent Opinion in Therapeutic Patents19911
46Overview: Novel Analogues of Mineralocorticoids, Antimineralocorticoids and Related CompoundsCurrent Opinion in Therapeutic Patents19911
47Overview: Recent Aspects of Transgene TechnologyCurrent Opinion in Therapeutic Patents19911
48Patent Update: Adhesion Molecules: Mediators of Inflammation and the Immune SystemCurrent Opinion in Therapeutic Patents19911
49Anti-allergic, antihistamine/H1-antagonist: 1-Alkoxyalkyl-2-alkylthiobenzimidazoles as Highly Potent AntihistaminesCurrent Opinion in Therapeutic Patents19911
50Patent Evaluation: Detection and Modulation of Gene Expression by OligonucleotidesCurrent Opinion in Therapeutic Patents19921